Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Drug, drugs history

Covers the body and mind in sickness and in health, including drugs, surgery, history, institutions, medical vocabulary and many other aspects. Highly commendable - Journal of the Institute of Health Education... [Pg.439]

When obtaining the drug history, the nurse must always question the patient about the use of herbs, teas, vitamins, or other nutritional or dietary supplements. Many patients consider herbs as natural and therefore safe It is also difficult for some to report the use of an herbal tea as a part of the health care regimen. Display 1-4 identifies teaching points to consider when discussing the use of herbs and nutritional supplements with patients. Although a complete discussion about the use of herbs is beyond the scope of this book, it is important to remember that the use of herbs and nutritional supplements is commonplace in many areas of the country. To help the student become more aware of herbal therapy and nutritional supplements, Appendix B gives... [Pg.13]

When taking the drug history of Mr. Woods, a patient in the outpatient clinic, you note that he has been taking... [Pg.90]

During the preadministration assessment, the nurse obtains a complete drug history. In addition, the nurse... [Pg.182]

The primary health care provider has prescribed cime-tidine for the treatment of a duodenal ulcer in Mr. Talley, who is 68 years old. A drug history by the nurse reveals that Mr. Talley is also taking the following drugs Lanoxin 0.5 mg orally each day and a daily aspirin tablet. Analyze this situation. Discuss what you would tell Mr. Talley. [Pg.486]

The factors that correlate with treatment success do not clearly apply to success after detoxification from methadone maintenance. Correlates of successful detoxification include 1) less criminal behavior 2) more stable family 3) more stable employment 4) shorter drug history 5) long maintenance with lower dosage and 6) discharge status, with patient and staff consensus as opposed to unilateral discharge from treatment (Dole and Joseph 1978). In one study, addicts were followed an average of 2 years after detoxification (Stim-mel et al. 1977). Although only 28% of the total sample remained abstinent, 83% of those who had fully completed treatment remained abstinent. Another study of 105 patients detoxified after methadone maintenance treatment documented an 82% relapse rate within 12 months (Ball and Ross 1991). These... [Pg.83]

The third protocol is to determine the level of drug use and calculate equivalent doses of phenobarbital (Table 3-5). The patient is stabilized on this dose (divided into administration every 8 hours) for a few days, and then the dose is tapered by 10% daily. Although this method has its proponents, the determination of equivalency is an approximation, drug histories are unreliable, and mixed sedative-hypnotic dependence will complicate the procedure. [Pg.146]

A comprehensive assessment of the stimulant-dependent patients psychological, medical, forensic, and drug use history may be difficult, because information may be incomplete or unreliable. In recognition of this deficiency, it is important that the patient receives a thorough physical examination, as well... [Pg.192]

A second approach might be to measure dopamine and serotonin along with their metabolites and other specific neuronal constituents such as tyrosine hydroxylase and tryptophan hydroxylase or uptake carrier sites in brain tissue obtained at autopsy. Accumulating data in this way might be a slow and tedious process, and drug dosing history might be uncertain and variable nonetheless, the approach deserves consideration. [Pg.349]

Obtain a thorough and accurate drug history, including the use of non-prescription drugs such as NSAIDs. [Pg.372]

Before administering any medication, take a thorough drug history to establish any past allergic or adverse reactions experienced by the patient. [Pg.827]

It is important to review the patient s medication history for potential drug-drug and drug-glaucoma interactions, adherence, presence of systemic and ocular adverse drug reactions, and ability to use ophthalmic preparations. [Pg.909]

Antimicrobial history Drug allergy history Renal and hepatic function Concomitant medications Pregnancy or lactation Compliance potential... [Pg.1026]

A thorough drug allergy history should be taken to discern true allergy (anaphylaxis) from adverse event (stomach upset). [Pg.1231]

Milestones in U.S. Food and Drug Law History, Publ. (FDA) 73-1018, U.S. Dept, of Health, Education, and Welfare, Food and Drug Administration, Washington, DC, 1972. [Pg.642]

Soar K, Turner JJD and Parrott AC (2001). Psychiatric disorders in recreational Ecstasy (MDMA) users A literature review focusing upon personal predisposition factors and drug histories. Human Psychopharmacology, 16, 641-645. [Pg.283]

Perrine, Daniel M. The Chemistry of Mind-Altering Drugs History, Pharmacology, and Cultural Context. Washington, DC American Chemical Society, 1996. [Pg.402]

Evaluation of the anxious patient requires a complete physical and mental status examination appropriate laboratory tests and a medical, psychiatric, and drug history. [Pg.751]

Factors that influence the choice of antidepressant include the patient s history of response, history of familial response, concurrent medical conditions, presenting symptoms, potential for drug-drug interactions, comparative side-effect profiles of various drugs, patient preference, and drug cost. [Pg.794]

Henderson, G.L. Designer Drugs Past History and Future Prospects. Journal of Forensic Science 33 (1988) 569-575. [Pg.83]

Farina, P.R., Homon, C.A., Lazer, E.S., and Parks, T.P., Discovery of BIRM 270 a new class of leukotriene biosynthesis inhibitors, in The Search for Anti-Inflammatory Drugs, Case Histories from Concept to Clinic, Merluzzi, V.J. and Adams, ]., Eds., Birkheauser, Boston, 1995, chap. 9. [Pg.97]

Source From Milestones in U.S. Food and Drug Law History, www.fda.gov/opacom/backgrounders/miles.html... [Pg.495]

Drugs—Research—History. 2. Drugs—Design—History. [Pg.660]


See other pages where Drug, drugs history is mentioned: [Pg.47]    [Pg.71]    [Pg.72]    [Pg.78]    [Pg.78]    [Pg.165]    [Pg.172]    [Pg.362]    [Pg.100]    [Pg.201]    [Pg.50]    [Pg.133]    [Pg.145]    [Pg.532]    [Pg.578]    [Pg.613]    [Pg.1029]    [Pg.1234]    [Pg.776]    [Pg.65]    [Pg.163]    [Pg.281]    [Pg.458]    [Pg.144]    [Pg.526]   
See also in sourсe #XX -- [ Pg.44 ]




SEARCH



A Brief and Superficial History of Statistics for Drug Developers

Antidepressant drugs history

Antipsychotic drugs history

Antithrombotic drugs history

Drug design/discovery history

Drug development validation history

Drug history components

Drug history healthcare providers

Drug history immunizations

Drug history interviewing patient

Drug history medical records

Drug history patient

Drug history, elderly

Drug legislation, history

Drugs early history

Drugs history

Drugs history

Gold drugs history

Herbal drugs history

Heroin drug history

History and Principles of Drug Delivery Using Polymers

History of Drug Discovery and Development

History of sports drug testing

History, of drug use

History-taking, drugs, elderly

Patient data records, drug history

Patient drug history communication

Patient drug history components

Patient drug history immunizations

Patient drug history medical records

Patient drug history medication allergies

Patient drug history medications

Patient drug history patients

Patient drug history setting

Patient drug history subjective data

Regulation history, drug

Selected Drugs from Early Recorded History

Sulfa drugs history

The History of Federal Pharmacy Drug

The Use of Natural Products as Drugs in History

© 2024 chempedia.info